SCHEMBL18072957

SCHEMBL18072957

CCS(=O)(=O)c1c(-c2nc3cc(C(F)(F)F)cnc3n2C)sc2ccccc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 2/20 0.41
▸ ALDH1A1 P00352 8/20 0.37
▸ HPGD P15428 5/20 0.37
▸ PPARG P37231 3/20 0.37
▸ NCOA2 Q15596 3/20 0.37
▸ NCOA1 Q15788 3/20 0.37
▸ NCOA3 Q9Y6Q9 3/20 0.37
▸ GAA P10253 3/20 0.37
▸ LMNA P02545 3/20 0.36
▸ TP53 P04637 1/20 0.36
▸ KDM4E B2RXH2 5/20 0.35
▸ KMT2A Q03164 4/20 0.35
▸ MEN1 O00255 2/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ GABRP O00591 1/20 0.34
▸ GABRD O14764 1/20 0.34
▸ GABRA1 P14867 1/20 0.34
▸ GABRB1 P18505 1/20 0.34
▸ GABRG2 P18507 1/20 0.34
▸ GABRB3 P28472 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18072962 0.91 POLB (0.41) POLBALDH1A1HPGDPPARGNCOA2
SCHEMBL19712029 0.91 POLB (0.41) POLBALDH1A1HPGDPPARGNCOA2
SCHEMBL19299798 0.89 POLB (0.40) POLBALDH1A1HPGDPPARGNCOA2
SCHEMBL19299804 0.89 POLB (0.40) POLBALDH1A1HPGDPPARGNCOA2
SCHEMBL19299827 0.88 POLB (0.40) POLBALDH1A1HPGDPPARGNCOA2
SCHEMBL18050266 0.88 POLB (0.40) POLBALDH1A1HPGDPPARGNCOA2
SCHEMBL19299828 0.88 POLB (0.40) POLBALDH1A1HPGDPPARGNCOA2
SCHEMBL19985657 0.87 POLB (0.39) POLBALDH1A1HPGDPPARGNCOA2
SCHEMBL19299800 0.87 POLB (0.40) POLBALDH1A1HPGDPPARGNCOA2
SCHEMBL19299825 0.87 POLB (0.40) POLBALDH1A1HPGDPPARGNCOA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10494368-B2 Pesticidally active tetracyclic derivatives with sulfur containing substituents SYNGENTA PARTICIPATIONS AG (CH) 2019-12-03 — — US disclosed
EP-3268361-B1 PESTICIDALLY ACTIVE TETRACYCLIC DERIVATIVES WITH SULFUR CONTAINING SUBSTITUENTS SYNGENTA PARTICIPATIONS AG (CH) 2019-09-18 — — EP disclosed
US-20190040060-A1 PESTICIDALLY ACTIVE TETRACYCLIC DERIVATIVES WITH SULFUR CONTAINING SUBSTITUENTS SYNGENTA PARTICIPATIONS AG (CH) 2019-02-07 — — US disclosed
US-20180079748-A1 PESTICIDALLY ACTIVE TETRACYCLIC DERIVATIVES WITH SULFUR CONTAINING SUBSTITUENTS SYNGENTA PARTICIPATIONS AG (CH) 2018-03-22 — — US disclosed
US-20180079748-A1 PESTICIDALLY ACTIVE TETRACYCLIC DERIVATIVES WITH SULFUR CONTAINING SUBSTITUENTS SYNGENTA PARTICIPATIONS AG (CH) 2018-03-22 — — US disclosed
WO-2017144341-A1 CONDENSED BICYCLIC HETEROCYCLE DERIVATIVES AS PEST CONTROL AGENTS BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2017-08-31 — — WO disclosed
WO-2016142327-A1 PESTICIDALLY ACTIVE TETRACYCLIC DERIVATIVES WITH SULFUR CONTAINING SUBSTITUENTS SYNGENTA PARTICIPATIONS AG (CH) 2016-09-15 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190040060-A1 PESTICIDALLY ACTIVE TETRACYCLIC DERIVATIVES WITH SULFUR CONTAINING SUBSTITUENTS DDT, TST, ACHE POLB 3735/4885ALDH1A1 892/4885HPGD 2495/4885
US-10494368-B2 Pesticidally active tetracyclic derivatives with sulfur containing substituents DDT, TST, ACHE POLB 3735/4885ALDH1A1 892/4885HPGD 2495/4885
US-20180079748-A1 PESTICIDALLY ACTIVE TETRACYCLIC DERIVATIVES WITH SULFUR CONTAINING SUBSTITUENTS DDT, TST, ACHE POLB 3774/4885ALDH1A1 1060/4885HPGD 2292/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback